TPTX » Topics » Life Science Research Israel, Ltd.

These excerpts taken from the TPTX 10-K filed Mar 31, 2008.

Life Science Research Israel, Ltd.

        In May 2004, we entered into a research and license agreement with Life Science Research Israel, Ltd. ("LSRI"). Under the agreement, we were required to make research funding payments to LSRI totaling $800,000 over a two-year period. Through December 31, 2007, we had made payments totaling $800,000. We are also subject to certain milestone and royalty payments as specified in the agreement. Through December 31, 2007, we had made payments totaling $2,150,000.

Life Science Research Israel, Ltd.



        In May 2004, we entered into a research and license agreement with Life Science Research Israel, Ltd. ("LSRI"). Under the agreement, we were required to
make research funding payments to LSRI
totaling $800,000 over a two-year period. Through December 31, 2007, we had made payments totaling $800,000. We are also subject to certain milestone and royalty payments as
specified in the agreement. Through December 31, 2007, we had made payments totaling $2,150,000.



This excerpt taken from the TPTX 10-K filed Mar 29, 2007.

Life Science Research Israel, Ltd.

In May 2004, the Company entered into a research and license agreement with Life Science Research Israel, Ltd. (“LSRI”). Under the agreement, the Company was required to make research funding payments to LSRI totaling $800,000 over a two-year period. Through December 31, 2006, the Company had made payments totaling $800,000.

The Company is also subject to certain milestone and royalty payments as specified in the agreement. Through December 31, 2006, the Company had made payments totaling $2,150,000.

This excerpt taken from the TPTX 8-K filed Dec 13, 2006.

Life Science Research Israel, Ltd.

In May 2004, the Company entered into a research and license agreement with Life Science Research Israel, Ltd. (“LSRI”). Under the agreement, the Company is required to make research funding payments to LSRI totaling $800,000 over a two-year period in equal quarterly installments. As of December 31, 2005, the Company had made payments totaling $700,000.

The Company is also subject to certain milestone and royalty payments as specified in the agreement. As of December 31, 2005, the Company had made payments totaling $250,000. The Company is required to make a payment of $150,000 on May 10, 2006.

12




 

RELATED TOPICS for TPTX:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki